TickerFacts.

NRC Health (NRC): Shareholders' Equity

Annual figures by period end, from SEC filings.

$13.99M
As of 2025-12-31
$6.55M
As of 2026-06-30
-42.1%
3-year compound annual growth
-26.3%
5-year compound annual growth
-15.4%
10-year compound annual growth
$90.04M2009-12-31: $44.17M2010-12-31: $48.58M2011-12-31: $55.55M2012-12-31: $56.74M2013-12-31: $71.75M2014-12-31: $87.75M2015-12-31: $74.22M2016-12-31: $82.81M2017-12-31: $90.04M2018-12-31: $19.08M2019-12-31: $32.89M2020-12-31: $64.31M2021-12-31: $85.34M2022-12-31: $72.03M2023-12-31: $48.95M2024-12-31: $31.28M2025-12-31: $13.99M$13.99M
2009-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$13.99M-55.3%2026-03-05, Balance as of period end
2024-12-31$31.28M-36.1%2026-03-05, Balance as of period end
2023-12-31$48.95M-32.0%2026-03-05, Balance as of period end
2022-12-31$72.03M-15.6%2025-03-17, Balance as of period end
2021-12-31$85.34M+32.7%2024-02-27, Balance as of period end
2020-12-31$64.31M+95.5%2023-03-03, Balance as of period end
2019-12-31$32.89M+72.4%2022-03-04, Balance as of period end
2018-12-31$19.08M-78.8%2021-03-05, Balance as of period end
2017-12-31$90.04M+8.7%2020-03-06, Balance as of period end
2016-12-31$82.81M+11.6%2019-03-08, Balance as of period end
2015-12-31$74.22M-15.4%2018-03-14, Balance as of period end
2014-12-31$87.75M+22.3%2017-03-03, Balance as of period end
2013-12-31$71.75M+26.5%2016-03-04, Balance as of period end
2012-12-31$56.74M+2.1%2015-03-04, Balance as of period end
2011-12-31$55.55M+14.3%2014-03-04, Balance as of period end
2010-12-31$48.58M+10.0%2014-03-04, Balance as of period end
2009-12-31$44.17Mn/a2012-03-01, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
NRC Health (NRC)2025-12-31$13.99M-55.3%
MaxCyte, Inc. (MXCT)2025-12-31$171.49M-16.9%
OmniAb, Inc. (OABI)2025-12-31$267.03M-7.2%
Foxo Technologies Inc. (FOXO)2025-12-31$11.14M+109.3%
Medpace Holdings, Inc. (MEDP)2025-12-31$459.07M-44.4%
bioAffinity Technologies, Inc. (BIAF)2025-12-31$7.28M+179.7%
Charles River Laboratories International, Inc. (CRL)2025-12-27$3.17B-8.6%
Incyte Corp (INCY)2025-12-31$5.17B+49.9%
Absci Corp (ABSI)2025-12-31$189.45M+5.8%

Compare NRC, MXCT, OABI, FOXO side by side · Screen every company in Services-Commercial Physical & Biological Research ↗